These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8781354)

  • 41. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Liver transplantation for hepatocellular carcinoma: status quo and experience in Kyushu University].
    Soejima Y; Taketomi A; Ikegami T; Yoshizumi T; Uchiyama H; Gion T; Sugimachi K; Nagata S; Maehara Y
    Fukuoka Igaku Zasshi; 2008 May; 99(5):95-101. PubMed ID: 18788452
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
    Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
    Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatectomy for hepatocellular carcinoma in a renal transplant patient--report of a case and literature review.
    Kamiya K; Suzuki S; Sakaguchi T; Konno H; Baba S; Nakamura S; Ishikawa A; Suzuki K; Fujita K
    Hepatogastroenterology; 2000; 47(33):835-8. PubMed ID: 10919042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma.
    Tanabe G; Ueno S; Maemura M; Kihara K; Aoki D; Yoshidome S; Ogura Y; Hamanoue M; Aikou T
    Hepatogastroenterology; 2001; 48(38):506-10. PubMed ID: 11379343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation.
    Roberts JP
    Liver Transpl; 2005 Nov; (11 Suppl 2):S45-6. PubMed ID: 16237702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgical treatment of hepatocellular carcinoma in cirrhosis].
    Farges O; Belghiti J
    Ann Chir; 1998; 52(6):535-42. PubMed ID: 9752503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of adult living liver donation in patients with hepatocellular cancer.
    Roberts JP
    Liver Transpl; 2003 Oct; 9(10 Suppl 2):S60-3. PubMed ID: 14528431
    [No Abstract]   [Full Text] [Related]  

  • 49. Resection of hepatocellular carcinoma.
    Franco D; Usatoff V
    Hepatogastroenterology; 2001; 48(37):33-6. PubMed ID: 11268993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
    Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
    Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
    [No Abstract]   [Full Text] [Related]  

  • 51. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.
    Kawamura Y; Ikeda K; Arase Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1739-46. PubMed ID: 18713301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential multidisciplinary treatment of hepatocellular carcinoma: the role of surgery as rescue therapy for failure of percutaneous ablation therapies.
    Portolani N; Baiocchi GL; Coniglio A; Grazioli L; Frassi E; Gheza F; Giulini SM
    J Surg Oncol; 2009 Dec; 100(7):580-4. PubMed ID: 19697354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation for hepatocellular carcinoma.
    Durand F; Belghiti J
    Hepatogastroenterology; 2002; 49(43):47-52. PubMed ID: 11941982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
    Gao ZH
    J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
    [No Abstract]   [Full Text] [Related]  

  • 55. Percutaneous ablation of liver tumors.
    Boyle MJ
    Arch Surg; 2003 Jul; 138(7):809; author reply 809-10. PubMed ID: 12860767
    [No Abstract]   [Full Text] [Related]  

  • 56. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
    Ijichi M; Takayama T; Matsumura M; Shiratori Y; Omata M; Makuuchi M
    Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma.
    Sakata J; Shirai Y; Wakai T; Kaneko K; Hatakeyama K
    Eur J Surg Oncol; 2008 Apr; 34(4):433-8. PubMed ID: 17475439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. To biopsy or not to biopsy?
    Perkins JD
    Liver Transpl; 2006 May; 12(5):885-6. PubMed ID: 16708420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.